The pressing questions in multiple sclerosis Care in the era of COVID-19

• MS patients should continue their disease modifying therapy during the pandemic. • Newly diagnosed patients should start disease modifying therapy without delay. • The effect on COVID-19 infection and future vaccination should be considered. • Agents that cause prolonged non-selective lymphopenia...

Descripción completa

Detalles Bibliográficos
Autores principales: Abboud, Hesham, Serra, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308765/
https://www.ncbi.nlm.nih.gov/pubmed/32599294
http://dx.doi.org/10.1016/j.jns.2020.117005
_version_ 1783549063728201728
author Abboud, Hesham
Serra, Alessandro
author_facet Abboud, Hesham
Serra, Alessandro
author_sort Abboud, Hesham
collection PubMed
description • MS patients should continue their disease modifying therapy during the pandemic. • Newly diagnosed patients should start disease modifying therapy without delay. • The effect on COVID-19 infection and future vaccination should be considered. • Agents that cause prolonged non-selective lymphopenia are not preferred. • Only severe relapses should be treated preferably with oral steroids at home.
format Online
Article
Text
id pubmed-7308765
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-73087652020-06-23 The pressing questions in multiple sclerosis Care in the era of COVID-19 Abboud, Hesham Serra, Alessandro J Neurol Sci Letter to the Editor • MS patients should continue their disease modifying therapy during the pandemic. • Newly diagnosed patients should start disease modifying therapy without delay. • The effect on COVID-19 infection and future vaccination should be considered. • Agents that cause prolonged non-selective lymphopenia are not preferred. • Only severe relapses should be treated preferably with oral steroids at home. Elsevier B.V. 2020-09-15 2020-06-23 /pmc/articles/PMC7308765/ /pubmed/32599294 http://dx.doi.org/10.1016/j.jns.2020.117005 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Abboud, Hesham
Serra, Alessandro
The pressing questions in multiple sclerosis Care in the era of COVID-19
title The pressing questions in multiple sclerosis Care in the era of COVID-19
title_full The pressing questions in multiple sclerosis Care in the era of COVID-19
title_fullStr The pressing questions in multiple sclerosis Care in the era of COVID-19
title_full_unstemmed The pressing questions in multiple sclerosis Care in the era of COVID-19
title_short The pressing questions in multiple sclerosis Care in the era of COVID-19
title_sort pressing questions in multiple sclerosis care in the era of covid-19
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308765/
https://www.ncbi.nlm.nih.gov/pubmed/32599294
http://dx.doi.org/10.1016/j.jns.2020.117005
work_keys_str_mv AT abboudhesham thepressingquestionsinmultiplesclerosiscareintheeraofcovid19
AT serraalessandro thepressingquestionsinmultiplesclerosiscareintheeraofcovid19
AT abboudhesham pressingquestionsinmultiplesclerosiscareintheeraofcovid19
AT serraalessandro pressingquestionsinmultiplesclerosiscareintheeraofcovid19

Ejemplares similares